Antibiotic resistance in Pseudomonas aeruginosa - Mechanisms, epidemiology and evolution
- PMID: 31492517
- DOI: 10.1016/j.drup.2019.07.002
Antibiotic resistance in Pseudomonas aeruginosa - Mechanisms, epidemiology and evolution
Abstract
Antibiotics are powerful drugs used in the treatment of bacterial infections. The inappropriate use of these medicines has driven the dissemination of antibiotic resistance (AR) in most bacteria. Pseudomonas aeruginosa is an opportunistic pathogen commonly involved in environmental- and difficult-to-treat hospital-acquired infections. This species is frequently resistant to several antibiotics, being in the "critical" category of the WHO's priority pathogens list for research and development of new antibiotics. In addition to a remarkable intrinsic resistance to several antibiotics, P. aeruginosa can acquire resistance through chromosomal mutations and acquisition of AR genes. P. aeruginosa has one of the largest bacterial genomes and possesses a significant assortment of genes acquired by horizontal gene transfer (HGT), which are frequently localized within integrons and mobile genetic elements (MGEs), such as transposons, insertion sequences, genomic islands, phages, plasmids and integrative and conjugative elements (ICEs). This genomic diversity results in a non-clonal population structure, punctuated by specific clones that are associated with significant morbidity and mortality worldwide, the so-called high-risk clones. Acquisition of MGEs produces a fitness cost in the host, that can be eased over time by compensatory mutations during MGE-host coevolution. Even though plasmids and ICEs are important drivers of AR, the underlying evolutionary traits that promote this dissemination are poorly understood. In this review, we provide a comprehensive description of the main strategies involved in AR in P. aeruginosa and the leading drivers of HGT in this species. The most recently developed genomic tools that allowed a better understanding of the features contributing for the success of P. aeruginosa are discussed.
Keywords: Antibiotic resistance; Fitness cost; Integrative and conjugative elements; Plasmids; Pseudomonas aeruginosa.
Copyright © 2019 Elsevier Ltd. All rights reserved.
Similar articles
-
Description of genomic islands associated to the multidrug-resistant Pseudomonas aeruginosa clone ST277.Infect Genet Evol. 2016 Aug;42:60-5. doi: 10.1016/j.meegid.2016.04.024. Epub 2016 Apr 21. Infect Genet Evol. 2016. PMID: 27108807
-
Characterization of clinical extensively drug-resistant Pseudomonas aeruginosa in the Hunan province of China.Ann Clin Microbiol Antimicrob. 2016 May 23;15(1):35. doi: 10.1186/s12941-016-0148-y. Ann Clin Microbiol Antimicrob. 2016. PMID: 27215335 Free PMC article.
-
Prevalence, Risk Factors, and Molecular Epidemiology of Intestinal Carbapenem-Resistant Pseudomonas aeruginosa.Microbiol Spectr. 2021 Dec 22;9(3):e0134421. doi: 10.1128/Spectrum.01344-21. Epub 2021 Nov 24. Microbiol Spectr. 2021. PMID: 34817230 Free PMC article.
-
[Carbapenemases in Pseudomonas spp].Enferm Infecc Microbiol Clin. 2010 Jan;28 Suppl 1:19-28. doi: 10.1016/S0213-005X(10)70004-5. Enferm Infecc Microbiol Clin. 2010. PMID: 20172419 Review. Spanish.
-
Pseudomonas aeruginosa epidemic high-risk clones and their association with horizontally-acquired β-lactamases: 2020 update.Int J Antimicrob Agents. 2020 Dec;56(6):106196. doi: 10.1016/j.ijantimicag.2020.106196. Epub 2020 Oct 9. Int J Antimicrob Agents. 2020. PMID: 33045347 Review.
Cited by
-
Niche, not phylogeny, governs the response to oxygen availability among diverse Pseudomonas aeruginosa strains.Front Microbiol. 2022 Aug 17;13:953964. doi: 10.3389/fmicb.2022.953964. eCollection 2022. Front Microbiol. 2022. PMID: 36060748 Free PMC article.
-
QSAR Models for Active Substances against Pseudomonas aeruginosa Using Disk-Diffusion Test Data.Molecules. 2021 Mar 19;26(6):1734. doi: 10.3390/molecules26061734. Molecules. 2021. PMID: 33808845 Free PMC article.
-
Multifaceted Interplay between Hfq and the Small RNA GssA in Pseudomonas aeruginosa.mBio. 2023 Feb 28;14(1):e0241822. doi: 10.1128/mbio.02418-22. Epub 2022 Dec 8. mBio. 2023. PMID: 36475775 Free PMC article.
-
Antibiotic Resistance in Pseudomonas.Adv Exp Med Biol. 2022;1386:117-143. doi: 10.1007/978-3-031-08491-1_5. Adv Exp Med Biol. 2022. PMID: 36258071
-
Pseudomonas aeruginosa Alters Peptidoglycan Composition under Nutrient Conditions Resembling Cystic Fibrosis Lung Infections.mSystems. 2022 Jun 28;7(3):e0015622. doi: 10.1128/msystems.00156-22. Epub 2022 May 12. mSystems. 2022. PMID: 35545925 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials